BioSyent Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	42.18	35.03	31.59	27.93	28.62	22.33
Revenue Growth (YoY)	22.22%	10.89%	13.13%	-2.42%	28.15%	4.24%
Cost of Revenue	9.51	7.17	5.99	5.07	5.98	4.91
Gross Profit	32.67	27.86	25.6	22.86	22.64	17.42
Selling, General & Admin	21.27	18.67	18.13	15.88	14.45	12.39
Operating Expenses	21.27	18.67	18.13	15.88	14.45	12.39
Operating Income	11.4	9.18	7.47	6.98	8.18	5.03
Interest Expense	-0.05	-0.06	-0.07	-0.08	-0.09	-0.09
Interest & Investment Income	0.88	1.09	1.13	0.53	0.16	0.26
Currency Exchange Gain (Loss)	-	-	-	-	-	0.04
EBT Excluding Unusual Items	12.23	10.21	8.53	7.43	8.25	5.24
Asset Writedown	-0.43	-0.43	-	-	-	-
Other Unusual Items	-	-	-	-	0.13	-
Pretax Income	11.8	9.78	8.53	7.43	8.38	5.24
Income Tax Expense	3.17	2.51	2.07	1.97	2.1	1.44
Net Income	8.63	7.27	6.46	5.46	6.28	3.8
Net Income to Common	8.63	7.27	6.46	5.46	6.28	3.8
Net Income Growth	21.47%	12.54%	18.35%	-13.11%	65.51%	-13.14%
Shares Outstanding (Basic)	11	12	12	12	13	13
Shares Outstanding (Diluted)	12	12	12	13	13	13
Shares Change (YoY)	-2.73%	-2.98%	-2.95%	-2.57%	-1.70%	-6.10%
EPS (Basic)	0.76	0.63	0.54	0.44	0.50	0.29
EPS (Diluted)	0.75	0.62	0.53	0.43	0.49	0.29
EPS Growth	24.83%	16.01%	22.07%	-10.86%	68.28%	-6.45%
Free Cash Flow	8.1	8.63	5	4.9	4.59	6.88
Free Cash Flow Per Share	0.70	0.73	0.41	0.39	0.36	0.53
Dividend Per Share	0.195	0.180	0.160	0.040	-	-
Dividend Growth	11.43%	12.50%	300.00%	-	-	-
Gross Margin	77.46%	79.52%	81.03%	81.85%	79.10%	78.02%
Operating Margin	27.04%	26.21%	23.65%	25.00%	28.59%	22.52%
Profit Margin	20.47%	20.75%	20.45%	19.55%	21.95%	16.99%
Free Cash Flow Margin	19.22%	24.64%	15.81%	17.55%	16.04%	30.81%
EBITDA	11.98	9.6	7.63	7.26	8.47	5.37
EBITDA Margin	28.40%	27.41%	24.15%	26.01%	29.60%	24.04%
D&A For EBITDA	0.58	0.42	0.16	0.28	0.29	0.34
EBIT	11.4	9.18	7.47	6.98	8.18	5.03
EBIT Margin	27.04%	26.21%	23.65%	25.00%	28.59%	22.52%
Effective Tax Rate	26.85%	25.68%	24.30%	26.54%	25.03%	27.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.